%0 Journal Article
%T Inflammatory lymphadenopathy in renal cell carcinoma: prognostic tool?
%A Ashwani Kumar Mishra
%A Hemant Goel
%A Purnima Malhotra
%J Archive of "Annals of Translational Medicine".
%D 2019
%R 10.21037/atm.2019.03.47
%X Significant lymphadenopathy in renal cell carcinoma (RCC) is often considered an important poor prognostic factor (1). A recent study by Muttin et al. (2) published in the World Journal of Urology attempts to refute this notion. As a pathologist, I am mighty pleased when he concludes that ˇ°a radiological suspicion of nodal metastases should not be considered as a poor prognostic factor, at least not until confirmation of nodal involvement at final pathologyˇ±
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545305/